Prevention of sexual acquisition of HIV in women requires a substantial increase in our knowledge about HIV-target cell availability and regulation in the female reproductive tract (FRT). In this study, we analyzed the phenotype and susceptibility to HIV infection of CD4 þ Tcell in the endometrium (EM), endocervix (END), and ectocervix (ECT) of the FRT.
INTRODUCTION
Currently, 34 million people are known to be infected with HIV and the pandemic continues to spread despite intensive preventive efforts. 1 Worldwide, approximately half of these infected persons are women; however, an imbalance between genders is found in areas like sub-Saharan Africa, where young women aged 15-24 years are up to eight times more likely to be infected than young men. [1] [2] [3] A combination of behavioral and biological factors may be involved in the differential incidence of infection between men and women. Intensive effort is being invested to try to prevent HIV infection in women, with mixed and disappointing results. 4 To develop successful approaches to prevent sexual acquisition of HIV in women, a considerable improvement in our knowledge is necessary regarding HIV-target cell distribution and regulation in the female reproductive tract (FRT). Although the pathogenesis of HIV infection is being widely studied in immune cells from blood, we are only starting to understand and unravel the complex interactions between HIV and the immune system in the FRT.
A unique characteristic of the FRT immune system is the dual task of protection against infection while allowing reproduction. Immune cells in the FRT are directly regulated by sex hormones throughout the menstrual cycle and indirectly by the mucosal microenvironment, which is also responsive to hormonal fluctuations. 5, 6 The direct effects of hormones on immune cells include changes in phenotype and activation status, 7 as well as the direct modification of susceptibility to HIV infection as we have recently demonstrated. 8 In that study, we found that estradiol treatment of CD4 þ T cells isolated from blood and monocyte-derived macrophages before HIV challenge reduced infection levels in a dose-dependent manner. Therefore, hormonal influence should be taken into account when analyzing HIV-target cells in the FRT. CD4 þ T cells are one of the main targets for HIV infection; however, not all CD4 þ T cells are equally susceptible to infection. 9 Studies in non-human primates indicate that memory CD4
þ T cells expressing C-C motif chemokine receptor 5 (CCR5) preferentially support HIV replication. demonstrated that HIV infection occurs preferentially with R5 viruses and that the majority of CD4
þ T cells present in these explants display an effector memory phenotype. 11 Experiments in macaques demonstrated that macrophageinflammatory protein 3a (C-C motif chemokine ligand 20 (CCL20)) was rapidly produced in response to simian immunodeficiency virus vaginal challenge and that blockade of this molecule resulted in the prevention of systemic dissemination of infection. 12 Macrophage-inflammatory protein 3a is a high-affinity ligand for CCR6 and will attract CCR6 þ cells to the infectious focus. Cells expressing CCR6 include immature dendritic cells, B cells, and a subset of CD4 þ T cells identified as T helper type 17 (Th17) cells. In addition to the CCR6 expression, Th17 cells are characterized by their production of interleukin (IL)-17 and expression of the transcription factor retinoic acid receptor-related orphan receptor C2 (RORC2), the human ortholog of RORgt expressed in the mouse. 13, 14 Th17 cells are mainly found in tissues, especially those in contact with the microbial environment, where they mediate immune responses to fungi and are important in maintaining the integrity of epithelial surfaces. 15, 16 Although Th17 cells have been broadly characterized in mucosal tissues such as the gut, lungs, or skin, with the exception of the endocervix, 16, 17 relatively little is known about their presence and distribution in other FRT tissues.
Several reports indicate that Th17 cells display high susceptibility to HIV infection and disappear early from the gut and cervix of HIV-infected patients. [17] [18] [19] [20] Th17 cells express higher levels of CCR5 and possess a memory phenotype, which may account for their increased HIV susceptibility. 18, 19 Furthermore, a recent study demonstrated the expression of CD90 (Thy-1) in a subset of Th17 cells isolated from blood that was depleted in non-treated HIV-infected patients. 21 In the present study, we characterized the distribution and phenotype of CD4 þ T cells at different sites in the FRT from premenopausal and postmenopausal women and compared their susceptibility to HIV infection. Understanding which cells are readily available to be infected, where they are located in the FRT, and the extent to which these cells are regulated by sex hormones and the mucosal tissue environment are essential to achieving successful prevention of sexual acquisition of HIV in women.
RESULTS

CD4
þ T-cell distribution in FRT tissues
Hysterectomy tissues were digested as described in Methods to obtain mixed cell suspensions. Differences in the distribution of CD4 þ T cells between endometrium (EM), endocervix (END), and ectocervix (ECT) were investigated analyzing CD3, CD4, and CD8 expression levels by flow cytometry (Figure 1a) . In EM, within the total T-cell population (CD3 þ ) (Figure 1b ), CD4 þ T cells accounted for approximately 35% of the CD3 þ cells present and were significantly lower than the CD3 þ CD4 À population (Po0.0001), which corresponds to CD8
þ T cells (Figure 1a) . In contrast, END and ECT CD4 þ T cells accounted for approximately 50% of the total CD3 þ cells (Figure 1b) . Comparison of CD3 þ CD4 þ T cells among the three FRT tissues showed significantly lower numbers of CD4 þ T cells in EM relative to those present in END and ECT (Figure 1b) .
To investigate whether the menstrual status of the patients would affect T-cell distribution in FRT tissues, we stratified samples according to premenopausal or postmenopausal status, as established by tissue histology. Menstrual status significantly influenced T-cell distribution in EM, but not in END or ECT, with premenopausal women containing a higher percentage of CD3 þ CD4 þ T cells (Figure 1c ) as compared with postmenopausal women. Additionally, in postmenopausal women, the percentage of CD4 þ T cells was lower in EM with respect to END or ECT (Figure 1c ).
Th17 cells constitute a major T-cell subset in the FRT
A previous report indicated that Th17 cells constitute an important T-cell subset in cervical cytobrush samples. 19 Therefore, we further characterized the immunophenotype of CD4 þ T cells in our hysterectomy samples by investigating the presence of Th17 subsets in the different FRT compartments. CD4
þ T cells were purified by negative selection to obtain an untouched pure population. After selection, EM, END, and ECT CD4 þ T-cell purity was490% (Figure 2a) . Reverse transcriptase-PCR analysis demonstrated that purified CD4 þ T cells from EM, END, and ECT express both RORC2 and IL-17, which identify Th17 cells 14, 15, 22 ( Figure 2b) . Additionally, CD4 þ T cells express CCL20, also described to be produced by Th17 cells (Figure 2b ). Gene expression of RORC2, IL-17, and CCL20 was the highest in END, followed by ECT, and the lowest in EM. We next explored how END gene expression without in vitro stimulation compared with gene expression in phytohemagglutinin-activated CD4 þ T cells from blood, which is known to upregulate Th17 markers. 23 As seen in Figure 2c , gene expression of RORC2, IL-17, and CCL20 was significantly higher in cervical samples relative to that seen in blood CD4 þ T cells. Additionally, gene expression of CCR7, which is known to be downregulated in tissue-resident T cells, 15 was significantly lower in CD4 þ T cells from END compared with blood. Similar patterns were seen when blood CD4 þ cells were compared with EM and ECT cells (not shown).
CD4
þ T cells from FRT express high levels of CCR6
As CCR6 is a defined surface marker for Th17 subsets, 13, 22 we analyzed expression of CCR6 in mixed cell suspensions from the different FRT sites. Expression of CCR6 in CD3 þ CD4 þ T cells was detected in all FRT tissues, but expression varied among anatomical sites (Figure 3a,b) . Median values for percentage of CCR6 þ cells were 11.3% in EM, 23.7% in END, and 15.2% in ECT ( Figure 3b) . As Th17 cells express the transcription factor RORC2 and produce IL-17, we performed intracellular staining to confirm that these cells were Th17 cells. The CCR6 þ population expressed RORC2 (Figure 3c,d ) and produced IL-17 in response to stimulation (Figure 3e) , corresponding to the Th17 subset.
We then analyzed the influence of menopausal status by stratifying the participants shown in Figure 3b into those corresponding to premenopausal (black dots) or postmenopausal (white dots) women (Figure 3f ). The number of CCR6 þ CD4 þ T cells in EM from premenopausal women was significantly lower than that seen in postmenopausal women. Additionally, when EM, END, and ECT premenopausal cells were compared, the number of CCR6 þ cells in END from premenopausal women was significantly greater than those found in EM. No differences were found among postmenopausal tissues (Figure 3f) .
Th17 cells are more susceptible to HIV infection, and it has been hypothesized that this is due to expression of higher levels of CCR5. [18] [19] [20] Therefore, we measured expression of CCR5 in CCR6 þ and CCR6 À CD4 þ T-cell subsets from the FRT. As seen in Figure 4a , an overlay of CCR6 þ and CCR6 À CD4 þ T cells demonstrated that CCR6 þ T cells (solid line) co-express higher levels of CCR5 than CCR6 À T cells (dashed line), whereas no differences in CD4 expression were found between both populations. As seen in Figure 4b , analysis of different donors confirmed that CCR5 expression was significantly higher in CCR6 þ than in CCR6 À CD4 þ T cells in the three FRT compartments analyzed. Subsequent stratification of the individuals shown in Figure 4b into premenopausal and postmenopausal women revealed significantly increased levels of CCR5 þ CCR6 þ T cells in postmenopausal women with respect to premenopausal women in EM. The same trend was observed in END and ECT although these differences did not reach statistical significance (Figure 4c, left graph) . No differences among CCR5 þ CCR6 À CD4 þ T cells were evident for either group (Figure 4c , right graph).
CD90 is highly expressed in CD4
þ T cells from the FRT CD90 was recently described in a small fraction of Th17 cells from blood, 21 but CD90expression is unknown in cells from the FRT. Therefore we investigated CD90 expression in CD4 
Differential susceptibility of CD4 þ T cells to HIV infection within FRT tissues
We hypothesized that differences in CD4 þ T-cell populations would result in differential susceptibility to HIV infection among FRT tissues and that CCR6 þ cells would be more susceptible to infection. To test this hypothesis, mixed cell suspensions from EM, END, and ECT were prepared and infected in vitro with HIV (BaL) as detailed in Methods. A low viral dose (multiplicity of infection ¼ 0.1) that gave detectable p24 and would help identify the most susceptible cells was chosen (see Supplementary Figure S1c online). Secreted p24 was detected in the supernatants at low levels ( Figure 6a ), as expected with the low viral input used, and infections were not productive, consistent with previous publications. 24 To identify the CD4 þ T cells producing p24, intracellular p24 was measured by flow cytometry 6 days after infection. The highest proportion of p24 þ T cells was found in ECT ( Figure 6b ). In contrast, p24 was detected only in two of the six EM samples analyzed. Next we asked whether CCR6 þ
CD4
þ T cells were more susceptible to HIV infection. As seen in Figure 6c , irrespective of the site analyzed, more CCR6 þ CD4 þ T cells were p24 þ than their corresponding CCR6 À population. We then explored the possibility that CD90 þ cells were more susceptible to infection. Following 6 days in culture, CD90 expression was decreased in uninfected controls relative to the initial values on day 0 (Figure 6d) . In infected cells ( Figure 6d , bottom row), CD90 expression was also reduced relative to day 0; however, expression was approximately 60% higher than the values measured in uninfected controls for END and ECT, with no changes in EM. Compared with uninfected controls on day 6, the CD4 þ T-cell population co-expressing CCR5 and CD90 doubled in HIV-infected samples from END (7.38% vs. 3.21%) and tripled in ECT (6.39% vs. 1.95%), with no changes in EM. We then analyzed p24 expression in each of the four quadrants of ECT-infected cells to see if infection was preferential to a given cell phenotype. As expected, all p24 þ cells were found in 
DISCUSSION
The characterization of the target cells in the FRT involved in sexual acquisition of HIV remains a major gap in our knowledge. In the present study, we compared phenotype, distribution, and susceptibility to HIV infection of CD4 þ T cells from EM, END, and ECT in premenopausal and postmenopausal women. Regarding differences in cell distribution between anatomical sites, CD4 þ T cells in general and Th17 cells in particular were lowest in EM compared with END and ECT. With respect to comparisons between premenopausal and postmenopausal tissues, postmenopausal women had reduced CD4 þ T cells, increased CD8 þ T cells, and increased Th17 cells in EM and increased CCR5 expression in Th17 cells from EM, END and ECT. In addition, we found decreased susceptibility to infection in CD4 þ T cells from EM compared with END and ECT.
Gene expression analysis of purified CD4 þ T cells from FRT tissues revealed expression of IL-17 and CCL20, cytokines produced by Th17 cells, and RORC2, the human ortholog of mouse RORgt, which is the master transcription factor involved in Th17 cell development. 14, 15 Consistent with gene expression profiles, a high proportion of CD4 þ T cells in the FRT had surface expression of CCR6, a marker for Th17 cells, intracellular RORC2, and produced IL-17 in response to stimulation. Although Th17 cells have been broadly studied in other mucosal surfaces, 16 to the best of our knowledge, our study is the first to compare Th17 subsets among FRT tissues. It is worth noting that CD4 þ T cells from the FRT showed a unique phenotype and gene expression profile compared with their blood counterparts. The proportion of T cells that we found in EM, and to a lesser extent in END and ECT, was markedly different than the levels found in peripheral blood, where CD3 þ CD4 þ T cells account for approximately 60-70% of the total T cells. Additionally, expression of IL-17, CCL20, and RORC2 was increased in CD4 þ T cells from END compared with blood, suggesting that CD4 þ T cells from each compartment may have unique innate and adaptive immune functions. As expected, CCR7 gene expression was reduced in CD4 þ T cells from the tissue compared with blood, consistent with the known downregulation of the chemokine receptor CCR7 during the development of tissue-resident memory T cells. 25 McKinnon et al. 19 recently characterized CD4 þ T cells collected by cytobrush, which recovers cells located on the surface of the cervical mucosa. In their study, Th17 cell frequency in cervix was enhanced compared with blood, and Th17 cells co-expressed CCR5. Our study complements these findings by analyzing the cells present within FRT tissues. We also found that Th17 cells were abundant in the FRT and constituted the main T-cell subset co-expressing CCR5. Additionally, our study indicates that within each tissue, Th17 cells are more susceptible to in vitro HIV infection than the rest of CD4 þ T cells. This finding is in agreement with preferential gp120 binding by Th17 cells described by McKinnon et al. 19 and with other studies previously indicating that Th17 cells from blood have increased susceptibility to HIV infection. 18, 20 Our studies demonstrate that CD4 þ T cells from END and ECT are more readily infected by HIV than cells from EM. Others have shown in non-human primates that the cervix is the first site of detectable simian immunodeficiency virus infection. 10, 12 Our results extend these findings, suggesting that in the human the cervix is the initial site of detectable HIV infection and demonstrating that not all CD4 þ T cells are equally susceptible to HIV infection. In contrast to END and ECT, HIV infection was detected in two out of six patients in EM. Reduced numbers of CD4 þ T cells, and in particular of Th17 cells, in EM with respect to END and ECT could partially explain the reduced susceptibility of this tissue to HIV infection. Further studies are needed to carefully identify the mechanisms in EM that restrict infection in CD4 þ T cells; this information could lead to the development of new preventive approaches.
Interestingly, our studies indicated that Th17 cells were more frequent in END than in ECT, but highest number of infected cells was found in ECT. Just why such differences were seen at adjacent sites remains to be determined. Plasticity and flexibility and the existence of intermediate subsets of Th17 cells have been reported, with alterations in lineage commitment that is regulated by the mucosal environment. 9, 26 In our studies, we measured expression of CCR6 but did not analyze additional chemokine receptors such as CCR4 and C-X-C motif chemokine receptor 3, which allow sub-classification into Th17 and Th1/Th17 subsets, respectively. Both subsets express RORC2, but their cytokine profiles are different and may display differential susceptibility to HIV infection. Another possible explanation is that upon entry into a given FRT tissue, the local environment influences phenotype and function of immune cells. Previously, we found that basolateral secretions from EM epithelial cells suppress DC-SIGN (dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin) and HIV trans-infection by blood-derived dendritic cells. 27 We found that CD8 þ T-cell function, measured as cytotoxic T lymphocyte activity, was suppressed during the secretory phase of the menstrual cycle in EM but not END or ECT. 28 Our findings in the present study demonstrate site phenotype specificity for CD4 þ T cells as well as selective susceptibility to HIV infection. Further studies are needed to understand the impact of the tissue environment on T-cell function in the FRT.
Here we describe for the first time that CD90 was highly expressed on CD4 þ T cells from the FRT, in particular in Th17 cells. Although CD90 is expressed in the majority of T cells in mice, CD90 expression in T cells from humans has only been reported in a small population of cortical thymocytes and o1% of T cells in peripheral blood.
29 CD90 (Thy-1) is a glycosyl phosphatidylinositol-anchored glycoprotein preferentially localized in lipid rafts. 29 CD90 appears to mediate cellto-cell interactions, participate in transferring of other glycosyl phosphatidylinositol-anchored proteins, such as CD55 and CD59, from one cell membrane to another 29 and was preferentially localized at the contact areas between infected and target cells. 30 We found a higher percentage of p24 þ cells in the population co-expressing CCR5 and CD90 than in cells expressing solely CCR5, which may suggest increased susceptibility to infection. Our data are in agreement with CD90 detection in a subset of Th17 cells from peripheral blood that was depleted during HIV infection, suggesting that this might represent a highly susceptible T-cell subset. 21 The role that CD90 may have in HIV acquisition remains unexplored, and future studies with purified cell populations need to determine their involvement in HIV acquisition. Although the physiological functions of this cell subset remain to be elucidated, selective targeting of CCR5 þ CD90 þ CD4 þ T cells may be an attractive strategy for preventing sexual acquisition of HIV in women.
Our studies also demonstrate that T-cell subsets in FRT tissues vary with menopausal status. Differences in CD4 þ T-cell distribution between premenopausal and postmenopausal women were found in EM but not in the other two compartments, suggesting regulation of T-cell subsets in the uterus. The CD4:CD8 T-cell ratio was decreased in EM from postmenopausal women, similar to previous findings in peripheral blood from postmenopausal women. [31] [32] [33] Additionally, we found that menopausal status affected Th17 frequency in FRT tissues. In premenopausal women, the proportion of Th17 cells was lower in EM than in END, likely contributing to the reduced HIV susceptibility of T cells from EM. In postmenopausal women, Th17 cells were significantly increased in EM with respect to premenopausal women, suggesting selective regulation of different T-cell subsets. Although in the present study we cannot demonstrate that the observed differences between premenopausal and postmenopausal women are due to hormonal changes, recent studies in mice demonstrated that estrogen deficiency promotes the differentiation of Th17 cells. 34 Ovariectomized mice had increased numbers of Th17 cells, and this effect could be reversed by estradiol supplementation. Downregulation of Th17 cells in EM of premenopausal women may be physiologically necessary for successful fertilization, implantation, and pregnancy, considering the reported Th17 cell increase in peripheral blood and decidual tissues from women with recurrent pregnancy loss. 35 Two main findings in our study support the reported increase in HIV susceptibility in postmenopausal women. 36, 37 First, we observed increased CCR5 expression in Th17 cells from postmenopausal women in all tissues analyzed, suggesting that these cells would be more susceptible to infection than those from premenopausal women. Although we could not compare HIV susceptibility between premenopausal and postmenopausal women in our cohort, we observed a trend for higher infection levels in cells from postmenopausal women. Second, we demonstrate that menopausal status correlates with the presence of HIV-susceptible CD4 þ T-cell populations in EM. The increase in Th17 cells in EM from postmenopausal women found in our study suggests that the EM is also a portal of entry for HIV in these women. Further research is needed to determine whether hormonal fluctuations throughout the menstrual cycle and hormonal shifts that occur with menopause directly modify the susceptibility of CD4 þ T cells to HIV infection in the FRT.
In conclusion, we demonstrate that Th17 cells are abundant in the FRT, that they display increased susceptibility to HIV infection, and that differential distribution and regulation of these cells may be responsible for the differential predisposition to infection of different FRT tissues. Our studies contribute important information for the development of preventive strategies oriented to target highly susceptible cells in the FRT.
METHODS
Study subjects. Studies were performed with Dartmouth College Institutional Review Board's approval. HIV-negative women undergoing hysterectomies at Dartmouth-Hitchcock Medical Center (Lebanon, NH) gave written informed consent before surgery. Approval to use tissues was obtained from the Committee for the Protection of Human Subjects. Indications for surgery were benign conditions and tissue samples distal from the sites of pathology and without pathological lesions were selected as determined by a pathologist. Women were not on oral contraceptives before hysterectomy. Menopausal status was determined by a pathologist based on the histological evaluation of sections of the EM (endometrial dating). Postmenopausal status was characterized by an atrophic EM. Age, surgical indication and menopausal status of each patient are shown in Table 1 . Information regarding genital infections was not obtained. þ T cells were isolated using negative magnetic bead selection with the CD4 þ T-cell isolation kit (Miltenyi Biotec) following instructions with minor modifications. This negative selection process depletes CD8, CD14, CD16, CD19, CD36, CD56, CD123, T-cell receptor g/d, and CD235a and delivers untouched CD3 þ CD4 þ T cells. Additionally, antifibroblast microbeads (Miltenyi Biotec) were added in combination with the microbeads supplied with the kit to ensure depletion of stromal fibroblasts present in the mixed cell suspension. After two rounds of negative selection, purity of the CD4 þ T-cell population was490% (see Figure 2a) . Yield recovery of CD4 þ T cells is shown in Supplementary Figure S1b . Following isolation, cells were analyzed by reverse transcriptase-PCR as described below, without in vitro stimulation. CD4 þ T cells from blood were isolated with the CD4 þ T-cell isolation kit (Miltenyi Biotec) following standard ficoll centrifugation and activated in vitro with Phytohemagglutinin (2.5 mg ml À 1 ; Sigma, St Louis, MO) and IL-2 (50 U ml À 1 ) (AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: Human rIL-2 from Dr Maurice Gately, Hoffmann-La Roche) 38 for 24 h as described before. 8 Flow cytometry. Mixed cell suspensions were stained for surface markers with combinations of the following antibodies: CD8-FITC (fluorescein isothiocyanate), CD4-FITC, CD4-PE (phycoerythrin), CD3-APC (allophycocyanin), CD3-APC-Cy7 (eBioscience, San Diego, CA), CCR5-PE-Cy7 (BD Biosciences, San Jose, CA), CCR5-PE (R&D Systems, Minneapolis, MN), CCR6-PerCp-Cy5.5, CD90 Alexa Fluor-647 (Biolegend, San Diego, CA). For the HIV-infection experiments, following infection for 6-7 days, intracellular levels of p24 were analyzed as described previously. 8 Briefly, after surface staining, cells were washed, fixed, and permeabilized (20 min) following instructions provided in the Cytofix/Cytoperm Plus kit (BD Biosciences) and stained for intracellular p24 with KC57-FITC antibody (Beckman Coulter, Danvers, MA) for 30 min. Analysis was performed on BD FACSCalibur or BD FACSCanto flow cytometers (BD Biosciences) using FACSdiva software, and data were analyzed with FlowJo software (Tree Star, Inc., Ashland, OR). Expression of surface markers was measured by the percentage of positive cells and the mean fluorescence intensity.
Intracellular staining. Detection of RORC2 and intracellular IL-17A was performed on mixed cell populations after removal of dead cells. For RORC2, cells were surface stained first and then fixed and permeabilized with the Foxp3 Fixation/permeabilization concentrate and diluent (eBioscience) according to the instructions. Intracellular staining of RORC was done using the anti-human/mouse ROR gamma (t)-APC antibody (eBioscience). For IL-17A staining, cells were activated with phorbol 12-myristate 13-acetate (Abcam, Cambridge, MA) and ionomycin (Calbiochem, Billerica, MA) for 5 h in the presence of Brefeldin A (BD GolgiPlug protein transport inhibitor, BD Biosciences), surface stained and fixed and permeabilized with the BD Cytofix/Cytoperm kit (BD Biosciences) according to the instructions. Intracellular staining of IL-17A was performed using the anti-human IL-17A-PE antibody (BD Biosciences).
RNA isolation and real-time PCR. Total RNA was extracted from purified CD4 þ T cells using the micro RNeasy kit (QIAGEN, Valencia, CA). DNase digestion was done on-column with the RNaseFree DNase set (Qiagen). After RNA quantification, cDNA was generated with the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). Real-time PCR was performed in duplicates using the 5 0 fluorogenic nuclease assay with TaqMan chemistry on the ABI 7300 Prism real-time PCR instrument (Applied Biosystems, Carlsbad, CA) as described before. 8 Primers and probe sets were obtained from Applied Biosystems assays-on-demand (RPL13A, RORC2, IL-17, CCL20, CCR7). Amplification conditions and analyses were performed as described previously 8 but using RPL13A as housekeeping gene. 39, 40 Results are presented as relative gene expression levels, calculated using the formula 2 À DC t . 41 For each gene, a difference in C t values (DC t ) was calculated by subtracting the mean C t for the housekeeping gene RPL13A from the mean C t of each gene of interest.
HIV infection. Mixed cell suspensions were infected with HIV-1 BaL for 2 h at a multiplicity of infection of 0.1 after which residual virus was washed away. The same input number of cells was used for EM, END, and ECT. Uninfected controls were incubated with medium without the virus for the same amount of time. After incubation, cells were plated in round bottom ultra low attachment 96-well plates (Corning, Corning, NY). Cell cultures were maintained for 6-7 days, with half of the well media collected and replaced with fresh media on day 3. At the end of the infection time, cells were washed, stained for surface markers as indicated, and levels of p24 measured intracellularly by flow cytometry (KC57-FITC; Beckman Coulter). Additionally, released p24 into the culture media was measured by p24 enzyme-linked immunosorbent assay (Advanced Bioscience Laboratories, Rockville, MD) following the manufacturer's recommendations.
Statistics. Data analysis was performed using the GraphPad Prism 5.0 software (GraphPad Software, Inc., La Jolla, CA). A two-sided P valueo0.05 was considered statistically significant. Comparison of the two groups was performed with the non-parametric MannWhitney U-test or Wilcoxon paired test. Comparison of three or more groups was performed applying the non-parametric Kruskal-Wallis test followed by Dunns post-test.
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